Chest-oscillation airway secretion-clearing system

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Disponible depuis:

MGC Diagnostics Australia Pty Ltd

classe:

Class IIa

Fabriqué par:

Respinnovation SAS 611 Chemin de l'Ardrech, Seillans, 83440 France

Domaine thérapeutique:

38124 - Chest-oscillation airway secretion-clearing system

indications thérapeutiques:

The RespIn 11 is intended to provide bronchial clearance therapy when external manipulation of the thorax is the physician's choice of treatment. Indications for this form of therapy are described by the American Association for Respiratory Care (AARC) in the Clinical Practices Guidelines for Postural Drainage Therapy' (1991). According to AARC guidelines, specific indications for external manipulation of the thorax include evidence or a suggestion of retained secretions, evidence that the patient is having difficulty with secretion clearance, or presence of atelectasis caused by mucus plugging. In addition, the RespIn 11 is also indicated for external manipulation of the thorax to promote bronchial clearance or improve bronchial drainage for purposes of collecting mucus for diagnostic evaluation

Statut de autorisation:

A

Date de l'autorisation:

2019-08-22